The ABPDU: A Catalyst for the U.S. Biomanufacturing Sector
During the COVID-19 pandemic, San Francisco startup Caspr Biotech developed a testing kit that doesn’t require results to be analyzed in centralized laboratories with trained personnel and sophisticated equipment. But the company was only able to produce …